Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Janagliflozin Tablets monotherapy in Chinese adults with type 2 diabetes mellitus
CTR20190347Phase 3Completed
- Sponsor
- Xuanzhu Biopharmaceutical
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of jagegliflozin in type 2 diabetes mellitus (T2DM), sponsored by Xuanzhu Biopharmaceutical. Started Mar 2019; status: completed.
02
Drugs
jagegliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20190347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190347.